ArticleAntioxidants (Basel, Switzerland)2023

Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk.

Alessia Silla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.